Sunday, May 10, 2015

EU approves Novartis' lung cancer drug Zykadia

Novartis’ lung cancer therapy Zykadia has bagged European … in ALK+ metastatic non-small cell lung cancer who have progressed on or … people are diagnosed worldwide with lung cancer, the leading cause of cancer …
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)